Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Desta

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Journal of Chromatography. B, Biomedical Sciences and Applications|September 19, 2000
Stereoselective determination of cisapride, a prokinetic agent, in human plasma by chiral high-performance liquid chromatography with ultraviolet detection: application to pharmacokinetic studyZ Desta, N V Soukhova, A Morocho, et al.
Journal of Clinical Pharmacology|October 22, 2013
Population pharmacogenetic-based pharmacokinetic modeling of efavirenz, 7-hydroxy- and 8-hydroxyefavirenzA M Abdelhady, Z Desta, F Jiang, et al.
Clinical Pharmacology and Therapeutics|February 10, 2012
Induction of CYP2C19 and CYP3A activity following repeated administration of efavirenz in healthy volunteersV Michaud, E Ogburn, N Thong, et al.
British Journal of Clinical Pharmacology|October 27, 2001
Stereoselective pharmacokinetics of cisapride in healthy volunteers and the effect of repeated administration of grapefruit juiceZ Desta, K T Kivistö, J J Lilja, et al.
The Pharmacogenomics Journal|May 15, 2003
Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6M Desai, J E Tanus-Santos, L Li, et al.
Clinical Pharmacology and Therapeutics|May 9, 2014
Prerequisites to implementing a pharmacogenomics program in a large health-care systemK D Levy, B S Decker, J S Carpenter, et al.
Clinical Pharmacology and Therapeutics|May 16, 2015
Identification and Mechanistic Investigation of Drug-Drug Interactions Associated With Myopathy: A Translational ApproachX Han, S K Quinney, Z Wang, et al.
Clinical Pharmacology and Therapeutics|May 14, 2015
Age-Related Changes in MicroRNA Expression and Pharmacogenes in Human LiverK S Burgess, S Philips, E A Benson, et al.
Journal of Musculoskeletal & Neuronal Interactions|June 3, 2010
Skeletal phenotype of mice with a null mutation in Cav 1.3 L-type calcium channelJ Li, L Zhao, I K Ferries, et al.
Clinical Pharmacology and Therapeutics|September 10, 2010
Estrogen receptor genotypes, menopausal status, and the effects of tamoxifen on lipid levels: revised and updated resultsD F Hayes, T C Skaar, J M Rae, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Journal of Chromatography. B, Biomedical Sciences and Applications|September 19, 2000
Stereoselective determination of cisapride, a prokinetic agent, in human plasma by chiral high-performance liquid chromatography with ultraviolet detection: application to pharmacokinetic studyZ Desta, N V Soukhova, A Morocho, et al.
Journal of Clinical Pharmacology|October 22, 2013
Population pharmacogenetic-based pharmacokinetic modeling of efavirenz, 7-hydroxy- and 8-hydroxyefavirenzA M Abdelhady, Z Desta, F Jiang, et al.
Clinical Pharmacology and Therapeutics|February 10, 2012
Induction of CYP2C19 and CYP3A activity following repeated administration of efavirenz in healthy volunteersV Michaud, E Ogburn, N Thong, et al.
British Journal of Clinical Pharmacology|October 27, 2001
Stereoselective pharmacokinetics of cisapride in healthy volunteers and the effect of repeated administration of grapefruit juiceZ Desta, K T Kivistö, J J Lilja, et al.
The Pharmacogenomics Journal|May 15, 2003
Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6M Desai, J E Tanus-Santos, L Li, et al.
Clinical Pharmacology and Therapeutics|May 9, 2014
Prerequisites to implementing a pharmacogenomics program in a large health-care systemK D Levy, B S Decker, J S Carpenter, et al.
Clinical Pharmacology and Therapeutics|May 16, 2015
Identification and Mechanistic Investigation of Drug-Drug Interactions Associated With Myopathy: A Translational ApproachX Han, S K Quinney, Z Wang, et al.
Clinical Pharmacology and Therapeutics|May 14, 2015
Age-Related Changes in MicroRNA Expression and Pharmacogenes in Human LiverK S Burgess, S Philips, E A Benson, et al.
Journal of Musculoskeletal & Neuronal Interactions|June 3, 2010
Skeletal phenotype of mice with a null mutation in Cav 1.3 L-type calcium channelJ Li, L Zhao, I K Ferries, et al.
Clinical Pharmacology and Therapeutics|September 10, 2010
Estrogen receptor genotypes, menopausal status, and the effects of tamoxifen on lipid levels: revised and updated resultsD F Hayes, T C Skaar, J M Rae, et al.
Pageof 4